- Home
- IOVA vs CCEC Comparison
IOVA vs CCEC Comparison
Compare IOVA & CCEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOVA
- CCEC
- Stock Information
- Founded
- IOVA 2007
- CCEC 2007
- Country
- IOVA United States
- CCEC Greece
- Employees
- IOVA N/A
- CCEC N/A
- Industry
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- CCEC Marine Transportation
- Sector
- IOVA Health Care
- CCEC Consumer Discretionary
- Exchange
- IOVA Nasdaq
- CCEC Nasdaq
- Market Cap
- IOVA 1.0B
- CCEC 1.1B
- IPO Year
- IOVA N/A
- CCEC 2007
- Fundamental
- Price
- IOVA $3.17
- CCEC $20.05
- Analyst Decision
- IOVA Strong Buy
- CCEC Buy
- Analyst Count
- IOVA 9
- CCEC 2
- Target Price
- IOVA $18.22
- CCEC $24.00
- AVG Volume (30 Days)
- IOVA 9.3M
- CCEC 23.5K
- Earning Date
- IOVA 05-08-2025
- CCEC 05-08-2025
- Dividend Yield
- IOVA N/A
- CCEC 2.88%
- EPS Growth
- IOVA N/A
- CCEC 45.68
- EPS
- IOVA N/A
- CCEC 3.38
- Revenue
- IOVA $164,070,000.00
- CCEC $402,628,000.00
- Revenue This Year
- IOVA $182.20
- CCEC $19.13
- Revenue Next Year
- IOVA $62.10
- CCEC $20.93
- P/E Ratio
- IOVA N/A
- CCEC $6.17
- Revenue Growth
- IOVA 13698.99
- CCEC 4.83
- 52 Week Low
- IOVA $2.70
- CCEC $14.09
- 52 Week High
- IOVA $13.60
- CCEC $20.70
- Technical
- Relative Strength Index (RSI)
- IOVA 43.38
- CCEC N/A
- Support Level
- IOVA $3.02
- CCEC N/A
- Resistance Level
- IOVA $3.73
- CCEC N/A
- Average True Range (ATR)
- IOVA 0.25
- CCEC 0.00
- MACD
- IOVA 0.01
- CCEC 0.00
- Stochastic Oscillator
- IOVA 25.33
- CCEC 0.00
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
About CCEC Capital Clean Energy Carriers Corp. Common Share
Capital Clean Energy Carriers Corp is an international shipping company. It is the leading platform of gas carriage solutions with a focus on the energy transition. The company owns 20 high-specification vessels, including 12 latest-generation LNG carriers (LNG/Cs) and eight legacy Neo-Panamax container vessels.